As Navratri approaches, it’s time to think about rejuvenating your investment portfolio, much like how we welcome the festive season. KSL brings you its top Navratri stock picks, created for their strong potential to deliver impressive gains. From pharmaceuticals to technology, each of these picks offers compelling reasons to join your portfolio this festive season.
Cipla: A Respiratory Powerhouse
Our first Navratri pick is Cipla. Currently trading at ₹1,657 with a target of ₹1,975, Cipla offers a potential upside of 19%. Known for its robust respiratory portfolio, Cipla is gaining significant traction in the US, especially after the successful launch of Lanreotide in Q1FY25. Additionally, Cipla is driving growth in India with a revamped distribution model and continued strong performance in South Africa. This health care giant is a great addition to your festive portfolio for a healthy boost in returns.
Tata Motors: Revving Up for Growth
Our second pick is Tata Motors, priced at ₹976 with a target of ₹1,151, representing an 18% potential upside. Tata Motors is set for a strong recovery in its Medium and Heavy Commercial Vehicle (MHCV) segment, supported by government infrastructure spending. With an impressive 84% market share in the EV segment, Tata Motors is positioned for sustained growth, despite challenges in the domestic passenger vehicle market. With two new models expected by March 2025, Tata Motors is a stock to watch this season.
Zomato: Expanding Beyond Food Delivery
Next up is Zomato, a digital services disruptor, trading at ₹276 with a target of ₹330 and a 20% upside. Zomato’s recent acquisition of Paytm’s ticketing business is set to boost revenues via its ‘District’ app, which now covers bookings for movies, sports, and live events. With additional expansions in food delivery, grocery, and recreational services, Zomato is strategically positioned for future growth. This is an exciting stock for those looking to capitalise on the digital economy.
Laurus Labs: Growing in API and Beyond
Laurus Labs is our fourth pick, trading at ₹461 with a target of ₹556, offering a 21% potential upside. Laurus Labs is experiencing strong growth in its API business, particularly in oncology, with gross margins benefiting from product mix improvements and optimised processes. Additionally, its animal health and crop protection units are on track for capacity expansions and qualifications, respectively. Laurus Labs is a strong pharmaceutical player in this Navratri portfolio.
Axis Bank: Poised for Strong Credit Growth
At ₹1,240, with a target of ₹1,409, Axis Bank presents a potential upside of 14%. As India’s third-largest private sector bank, Axis Bank is well-positioned for robust credit growth, projected to outpace the industry by 300-400 basis points. The bank continues to expand through technology investments and branch expansions, making it a stable and promising addition to your portfolio this festive season.
Pidilite: Adhesive Giant Sticking to Growth
Pidilite is next on our list, trading at ₹3,370 with a target of ₹3,800, offering a potential upside of 13%. Known for its dominance in the consumer & bazaar segments, Pidilite continues to outperform in rural markets, while its international subsidiaries have enhanced EBITDA margins significantly. With plans to expand capacity as demand surges, Pidilite is well-positioned for sustainable growth, making it a solid pick for your portfolio.
Cummins India: Powering the Future
Cummins India, trading at ₹3,810 with a target of ₹4,330, offers a 14% potential upside. As a leader in diesel and natural gas engines Cummins is capitalising on rising demand in power generation and data centres. With growth prospects in construction, railways, mining, and defence, Cummins is a powerhouse addition to your investment portfolio this festive season.
TCS: A Tech Titan for the Future
TCS, one of the world’s leading IT service companies, is currently priced at ₹4,270 with a target of ₹4,715, offering a 10% potential upside. TCS’s strong revenue visibility comes from long-term contracts and its leadership in the BFSI sector. With exciting new developments in AI and cloud solutions, TCS remains a trusted partner for digital transformation. This is a must-have tech stock for your portfolio.
Sun Pharma: Leading the Healthcare Revolution
Our final pick is Sun Pharma, trading at ₹1,934 with a target of ₹2,251, offering a 16% potential upside. With a growing market share in India and a portfolio of innovative products, Sun Pharma is poised for continued success. The company’s recent approval for NIDLEGY™ in Europe signals more growth on the horizon, making Sun Pharma a leader in healthcare and an essential stock in your portfolio this Navratri.
This Navratri, let these stocks from KSL light up your investment strategy, helping you achieve financial growth and prosperity. As the festival symbolises the triumph of good over evil, your portfolio too can triumph with these carefully selected picks, each poised for solid growth in the upcoming months.
Visit www.kslindia.com for more.